Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Rossella Talotta, Fabiola Atzeni & Magdalena Janina Laska. (2020) Retroviruses in the pathogenesis of systemic lupus erythematosus: Are they potential therapeutic targets?. Autoimmunity 53:4, pages 177-191.
Read now
Read now
Jenna Janiga, Jonathan Kentley, Chadi Nabhan & Farah Abdulla. (2018) Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome. Leukemia & Lymphoma 59:3, pages 562-577.
Read now
Read now
Midori Tanaka, Kyuzi Kamoi & Toru Takahashi. (2008) Interferon-alpha is a predisposing risk factor for carbamazepine-induced hyponatremia: A case of syndrome of inappropriate antidiuresis caused by interferon-alpha therapy. International Journal of General Medicine 1, pages 21-25.
Read now
Read now
Alexander N Khitrov, Zaur S Shogenov, Eugenia B Tretyak, Anatoly I Ischenko, Eiji Matsuura, Oliver Neuhaus, Mikhail A Paltsev & Sergey V Suchkov. (2007) Postinfectious immunodeficiency and autoimmunity: pathogenic and clinical values and implications. Expert Review of Clinical Immunology 3:3, pages 323-331.
Read now
Read now
Carol S. Portlock, Owen A. O'Connor, David J. Straus, Lisa Rosenzweig, Otilia Dumitrescu, Oscar Lin & Peter Maslak. (2006) Pegylated interferon plus rituximab in advanced stage, indolent lymphoma: is there CD20 antigen upregulation?. Leukemia & Lymphoma 47:7, pages 1260-1264.
Read now
Read now
Articles from other publishers (34)
Shu-Ming Chou, Hsing-Jung Yeh, Tzu-Min Lin, Yu-Sheng Chang, Hui-Ching Hsu, Yu-Chuan Shen, Tzu-Tung Kuo, Jin-Hua Chen, Shu-Chuan Chen & Chi-Ching Chang. (2022) Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study. Frontiers in Immunology 13.
Crossref
Crossref
Chien-Hsueh Tung, Yen-Chun Chen & Yi-Chun Chen. (2022) Association between Anti-Hepatitis C Viral Intervention Therapy and Risk of Sjögren’s Syndrome: A National Retrospective Analysis. Journal of Clinical Medicine 11:15, pages 4259.
Crossref
Crossref
Chien-Hsueh Tung, Ning-Sheng Lai, Chung-Yi Li, Shiang-Jiun Tsai, Yen-Chun Chen & Yi-Chun Chen. (2018) Risk of rheumatoid arthritis in patients with hepatitis C virus infection receiving interferon-based therapy: a retrospective cohort study using the Taiwanese national claims database. BMJ Open 8:7, pages e021747.
Crossref
Crossref
Michael Murphy, Goutham Pattabiraman, Tissa T. Manavalan & Andrei E. Medvedev. (2017) Deficiency in IRAK4 activity attenuates manifestations of murine Lupus. European Journal of Immunology 47:5, pages 880-891.
Crossref
Crossref
Justyna Roszkiewicz & Elzbieta Smolewska. (2016) Kaleidoscope of autoimmune diseases in HIV infection. Rheumatology International 36:11, pages 1481-1491.
Crossref
Crossref
Julianne N. P. Smith, Vikramjit S. Kanwar & Katherine C. MacNamara. (2016) Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia. Frontiers in Immunology 7.
Crossref
Crossref
Elena V. Tchetina, Anastasya N. Pivanova, Galina A. Markova, Galina V. Lukina, Elena N. Aleksandrova, Andrey P. Aleksankin, Sergey A. Makarov & Aleksandr N. Kuzin. (2016) Rituximab Downregulates Gene Expression Associated with Cell Proliferation, Survival, and Proteolysis in the Peripheral Blood from Rheumatoid Arthritis Patients: A Link between High Baseline Autophagy-Related ULK1 Expression and Improved Pain Control. Arthritis 2016, pages 1-12.
Crossref
Crossref
Mohammad Saeid Rezaee Zavareh, Seyed Moayed Alavian, Hamidreza Karimisari, Mostafa Shafiei & Seyed Yasser Saiedi Hosseini. (2014) Occult Hepatitis C Virus Infection in Patients With Autoimmune Hepatitis. Hepatitis Monthly 14:8.
Crossref
Crossref
Seyed Moayed Alavian. (2014) Determination of Whether Vitiligo is a Contraindication to Interferon Therapy in Chronic Hepatitis C. Journal of Skin and Stem Cell 1:1.
Crossref
Crossref
Bruno Cacopardo, Francesco Benanti, Marilia Rita Pinzone & Giuseppe Nunnari. (2013) Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature. BMC Research Notes 6:1.
Crossref
Crossref
Marwa Khairy, Maissa El‐Raziky, Wafaa El‐Akel, Mohamed S. Abdelbary, Hany Khatab, Badawy El‐Kholy, Gamal Esmat & Mahassen Mabrouk. (2013)
Serum autoantibodies positivity prevalence in patients with chronic
HCV
and impact on pegylated interferon and ribavirin treatment response
. Liver International 33:10, pages 1504-1509.
Crossref
Crossref
Micheline McCarthy & Melissa R. Ortega. (2012) Neurological Complications of Hepatitis C Infection. Current Neurology and Neuroscience Reports 12:6, pages 642-654.
Crossref
Crossref
Raghini Ranganathan, Krishnaveni Janarthanan & Senthilkumar Rajasekaran. (2012) Onset of Type 1 Diabetes Mellitus During Pegylated-interferon Alfa and Ribavirin Therapy for Chronic Hepatitis C Virus Infection. Journal of Clinical and Experimental Hepatology 2:1, pages 86-87.
Crossref
Crossref
Sonja Tattermusch, Jason A. Skinner, Damien Chaussabel, Jacques Banchereau, Matthew P. Berry, Finlay W. McNab, Anne O'Garra, Graham P. Taylor & Charles R. M. Bangham. (2012) Systems Biology Approaches Reveal a Specific Interferon-Inducible Signature in HTLV-1 Associated Myelopathy. PLoS Pathogens 8:1, pages e1002480.
Crossref
Crossref
Wen-li Zheng, Guang-sen Zhang, Jian-kai Shen, Min-fei Pei, Hong-ling Peng & Min Xu. (2011) Acquired factor VIII inhibitor as presentation of chronic myelogenous leukemia during interferon-alpha therapy. Thrombosis Research 128:2, pages 202-203.
Crossref
Crossref
Joerg-Patrick Stübgen. (2011) Drug-induced dysimmune demyelinating neuropathies. Journal of the Neurological Sciences 307:1-2, pages 1-8.
Crossref
Crossref
Kazuki Takeishi, Ken Shirabe, Takeo Toshima, Toru Ikegami, Kazutoyo Morita, Takasuke Fukuhara, Takashi Motomura, Yohei Mano, Hideaki Uchiyama, Yuji Soejima, Akinobu Taketomi & Yoshihiko Maehara. (2011) De novo autoimmune hepatitis subsequent to switching from type 2b to type 2a alpha-pegylated interferon treatment for recurrent hepatitis C after liver transplantation: Report of a case. Surgery Today 41:7, pages 1016-1019.
Crossref
Crossref
Christoph Domschke, Florian Schuetz, Yingzi Ge, Joachim Rom, Markus Zorn, Hans-Peter Sinn, Frederik Marmé, Sarah Schott, Joerg Heil, Alexander Scharf, Christof Sohn, Andreas Schneeweiss & Philipp Beckhove. (2010) Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients. Cancer Immunology, Immunotherapy 60:3, pages 401-411.
Crossref
Crossref
Savvas Ioannou, Gregorios Hatzis, Ioanna Vlahadami & Michael Voulgarelis. (2010) Aplastic anemia associated with interferon alpha 2a in a patient with chronic hepatitis C virus infection: a case report. Journal of Medical Case Reports 4:1.
Crossref
Crossref
A.M. Thornton. 2010. Comprehensive Toxicology. Comprehensive Toxicology
87
107
.
Joerg-Patrick Stübgen. (2009) Recombinant interferon-beta therapy and neuromuscular disorders. Journal of Neuroimmunology 212:1-2, pages 132-141.
Crossref
Crossref
M. Merli, F. Gentili, M. Giusto, A.F. Attili, S.G. Corradini, G. Mennini, M. Rossi, A. Corsi & P. Bianco. (2009) Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis c: Allo or autoimmune de novo hepatitis?. Digestive and Liver Disease 41:5, pages 345-349.
Crossref
Crossref
Joerg-Patrick Stübgen. (2009) Interferon alpha and neuromuscular disorders. Journal of Neuroimmunology 207:1-2, pages 3-17.
Crossref
Crossref
Pia Lebiedz, Christian August, Wolfram Domschke & Hartmut H.-J. Schmidt. (2009) Interferon (IFN) for malignant melanoma unmasking an autoimmune hepatitis. European Journal of Internal Medicine 20:1, pages e3-e4.
Crossref
Crossref
E. Vispo, I. Maida, A. Moreno, P. Barreiro & V. Soriano. (2008) Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C. Journal of Antimicrobial Chemotherapy 62:6, pages 1470-1472.
Crossref
Crossref
M. Cristina Lebre, Sarah L. Jongbloed, Sander W. Tas, Tom J.M. Smeets, Iain B. McInnes & Paul P. Tak. (2008) Rheumatoid Arthritis Synovium Contains Two Subsets of CD83−DC-LAMP− Dendritic Cells with Distinct Cytokine Profiles. The American Journal of Pathology 172:4, pages 940-950.
Crossref
Crossref
Romain Coriat & Philippe Podevin. (2008) Fulminant autoimmune hepatitis after successful interferon treatment in an HIV–HCV co-infected patient. International Journal of STD & AIDS 19:3, pages 208-210.
Crossref
Crossref
Angela Kallwellis-Opara, Andrea Dörner, Wolfgang-Christian Poller, Michel Noutsias, Uwe Kühl, Heinz-Peter Schultheiss & Mathias Pauschinger. (2007) Autoimmunological features in inflammatory cardiomyopathy. Clinical Research in Cardiology 96:7, pages 469-480.
Crossref
Crossref
Visith Thongboonkerd, Theptida Semangoen & Somchai Chutipongtanate. (2007) Enrichment of the Basic/Cationic Urinary Proteome Using Ion Exchange Chromatography and Batch Adsorption. Journal of Proteome Research 6:3, pages 1209-1214.
Crossref
Crossref
Nickolas Kontorinis, Kaushik Agarwal, Nassim Elhajj, M. Isabel Fiel & Thomas D. Schiano. (2006) Pegylated interferon–induced immune-mediated hepatitis post–liver transplantation. Liver Transplantation 12:5, pages 827-830.
Crossref
Crossref
P.J. Pinés-Corrales, M. Peralta-Watt, H. de la Calle, M. Alonso-Blanco & R. Barrio-Castellanos. (2006) Disfunción tiroidea autoinmunitaria de presentación variable en una paciente tratada con interferón-α. Endocrinología y Nutrición 53:2, pages 87-89.
Crossref
Crossref
Lars Rönnblom, Maija‐Leena Eloranta & Gunnar V. Alm. (2006) The type I interferon system in systemic lupus erythematosus. Arthritis & Rheumatism 54:2, pages 408-420.
Crossref
Crossref
Fernanda Elias, Juan Flo, Juan M. Rodriguez, Analia De Nichilo, Ricardo A. Lopez, Jorge Zorzopulos, Carlos Nagle, Mónica Lahoz & Alejandro Montaner. (2005) PyNTTTTGT prototype oligonucleotide IMT504 is a potent adjuvant for the recombinant Hepatitis B vaccine that enhances the Th1 response. Vaccine 23:27, pages 3597-3603.
Crossref
Crossref
. (2004) Current World Literature. Current Opinion in Allergy & Clinical Immunology 4:4, pages 329-334.
Crossref
Crossref